Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction

Background. Sacubitril/valsartan in heart failure (HF) with reduced ejection fraction (HFrEF) was shown to be superior to enalapril in reducing the risk of death and hospitalization for HF. Our aim was to evaluate the cardiopulmonary effects of sacubitril/valsartan in patients with HFrEF. Methods. W...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Vitale, Giuseppe, Romano, Giuseppe, Di Franco, Antonino, Caccamo, Giuseppa, Nugara, Cinzia, Ajello, Laura, Storniolo, Salvo, Sarullo, Silvia, Agnese, Valentina, Giallauria, Francesco, Novo, Giuseppina, Clemenza, Francesco, Sarullo, Filippo M.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6406731/
https://ncbi.nlm.nih.gov/pubmed/30791533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8020262
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars